JP Patent
JP7483776B2 — 放出制御pth化合物の漸増用量設定
Assigned to アセンディス ファーマ ボーン ディジージズ エー/エス · Expires 2024-05-15 · 2y expired
What this patent protects
Patent listed against Yorvipath.
Drugs covered by this patent
- Yorvipath (PALOPEGTERIPARATIDE) · Ascendis Pharma Bone
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.